Soleno Therapeutics's total assets for Q2 2025 were $332.31M, an increase of 4.47% from the previous quarter. SLNO total liabilities were $92.17M for the fiscal quarter, a 7.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.